NR1H2 and ovarian cancer: However, our studies demonstrated that ovarian cancer cell lines exhibiting low level of certain NER factors (XPF in CDDP, XPG in CP70) are still resistant to cisplatin, indicating the amount of NER proteins may not be a key determinant of NER efficiency.